Pancreatic Resection in Fit Octogenarians With Nonmetastatic Pancreatic Cancer
Summary
The NIH registered an observational clinical study (NCT07542782) examining survival outcomes of pancreatic cancer surgery and post-operative chemotherapy in patients aged 80 and older without metastatic disease, using data from a German cancer registry. The study compares patients who underwent surgical tumor resection with curative intent against those who did not, and further examines the role of additional treatment after surgery.
What changed
This is a clinical trial registry entry (NCT07542782) filed with ClinicalTrials.gov by the NIH, registering an observational study on pancreatic cancer treatment outcomes in fit octogenarians. The study will analyze data from a German cancer registry to compare survival between patients who undergo surgical resection versus no surgery, and between those who receive post-operative chemotherapy versus those who do not.
This registry entry is informational and does not create compliance obligations. Healthcare providers, clinical investigators, and patients interested in pancreatic cancer surgical outcomes in elderly populations may reference this study for awareness of ongoing research.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Pancreatic Resection in Fit Octogenarians With Nonmetastatic Pancreatic Cancer
Observational NCT07542782 Kind: OBSERVATIONAL Apr 21, 2026
Abstract
This study looks at how different treatment approaches affect survival in older people with pancreatic cancer that has not spread to other parts of the body. In particular, it focuses on patients aged 80 years and older who are still in relatively good general health and able to carry out normal daily activities.
Pancreatic cancer is a serious disease, and surgery to remove the tumor is often the only treatment that offers a chance of longer survival. However, older patients are less likely to receive surgery, even if they are otherwise fit. Doctors may hesitate to recommend surgery mainly because of the patient's age, rather than their overall health condition. This study aims to better understand whether surgery can still be beneficial for these older patients.
The study also examines the role of additional treatment after surgery, such as chemotherapy. In real-world medical practice, not all patients receive this follow-up treatment, especially older individuals who may have a slower recovery after surgery. This can make it difficult to understand whether such treatments truly improve survival.
To answer these questions, the study uses data from a large cancer registry in Germany. It compares patients who had surgery with those who did not, and it also looks at patients who received additional treatment after surgery versus those who did not. Special methods are used to take into account that some patients may not have been able to receive further treatment because t...
Conditions: Pancreatic Cancer
Interventions: All types of surgical tumor resection procedures with curative intent, No surgical resection
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.